Xeloda
information and resources from the National Cancer Institute
Xeloda
(Other name for: capecitabine)Xeloda
(Other name for: capecitabine)
capecitabine
Accel. Approv. (clinical benefit subsequently established) Treatment of metastatic breast cancer resistant to both paclitaxel and an anthracycline containing chemotherapy regimen or resistant to paclitaxel and for whom further anthracycline therapy may be contraindicated, e.g., patients who have received cumulative doses of 400 mg/m2 of doxorubicin or doxorubicin equivalents
Roche Apr 30 1998
capecitabine
Initial therapy of patients with metastatic colorectal carcinoma when treatment with fluoropyrimidine therapy alone is preferred. Combination chemotherapy has shown a survival benefit compared to 5-FU/LV alone. A survival benefit over 5_FU/LV has not been demonstrated with Xeloda monotherapy.
Roche Apr 30 2001
capecitabine
Treatment in combination with docetaxel of patients with metastatic breast cancer after failure of prior anthracycline containing chemotherapy
Roche Sep 07 2001
|
|
|
|
news articles
Phase II Trial of Taxotere® and Xeloda® for Metastatic Gastric ... Mar 30, 2006
Cancer Consultants (press release), ...of metastatic adenocarcinoma of the stomach or gastroesophageal junction with the chemotherapy drugs Taxotere® (docetaxel) and Xeloda® (capecitabine) reduced ...
Health Canada approves Xeloda(R) for adjuvant therapy in the ... Mar 28, 2006
Canada NewsWire (press release), ...announced today that Health Canada has approved XELODA (capecitabine), an innovative oral chemotherapy, for the adjuvant treatment of patients with stage III ...
Health council urges NIS 466m. expansion of services Mar 29, 2006
Jerusalem Post, Levemir, Humalog, Apidra and Novorapid (for diabetics, eliminating previous restrictions); Eloxatin for stage III colorectal cancer and Xeloda (for adjuvant ...
Novacea Appoints Amar Singh as Chief Commercialization Officer Mar 15, 2006
Market Wire (press release) ...where he led the launches of XELODA®, a novel oral chemotherapeutic agent for the treatment of metastatic breast cancer, and KYTRIL®, an anti-nausea agent ...
Bortezomib (Velcade) and Capecitabine (Xeloda) in Combination ... Dec 9, 2005
DG News SAN ANTONIO, TX -- December 9, 2005 -- A small phase 1 study has shown that bortezomib (Velcade) used in combination with capecitabine (Xeloda) is safe and well ...
Xeloda®/Eloxatin®/Avastin® (XeloxA) Highly Active in Newly ... Nov 18, 2005
Cancer Consultants (press release), ...a 57% complete and partial remission rate for patients with metastatic colorectal cancer following treatment with treatment with Xeloda (capecitabine) and ...
Being in dark on pancreatic cancer is deadly Nov 28, 2005
Fort Wayne Journal Gazette, ...treatment, and later two clinical trials – Avastin, which was approved for colorectal cancer but not pancreatic cancer, and an oral chemo called Xeloda. ...
|
|
